CFO
SRPT icon

CVA Family Office’s Sarepta Therapeutics SRPT Stock Holding History

CVA Family Office’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$222 Buy
13
+7
+117% +$120 ﹤0.01% 1268
2025
Q1 		$383 Buy
+6
New +$383 ﹤0.01% 1362